Global Industry News

Magnesium Stearate Improving Cosmetics Quality

The expanding pharmaceutical industry, especially in Asia-Pacific (APAC), is expected to drive the global magnesium stearate market from $1,492.3 million in 2019 to $2,637.6 million by 2030, at a 5.3% CAGR between 2020 and 2030. Being the most populated region in the world, APAC generates a significant requirement for medical drugs and other pharma products. In addition, heavy investments are being poured in the regional healthcare sector, which is leading to an increasing pharmaceutical output.

This factor is helping the magnesium stearate market grow, as the salt is used to prevent the sticking of drugs to production machines. The ability of the compound to serve as a cost-effective and suitable release agent propels its usage among pharmaceutical manufacturers. Thus, with the increasing pharmaceutical production in India, China, and Indonesia, the demand for this chemical will keep rising.

Due to the coronavirus pandemic, the magnesium stearate market has received a boost. This is because, with the rising cases of the infection, the healthcare sector is overburdened, with an acute shortage of drugs. Thus, pharmaceutical manufacturers have increased their output manifold, to meet the demand for medication, thereby driving the consumption of the compound.

The powder bifurcation, on the basis of form, is expected to witness the faster magnesium stearate market growth in the coming years. This is attributed to the wide usage of powdered magnesium stearate as a release agent, to make sure that the drugs do not stick to the manufacturing equipment. In addition, in several cosmetic products, including face powders and foundation cakes, the powdered form of the magnesium salt is used as an anti-caking agent. This is because it absorbs the extra moisture from the skin as well as prevents lumps from forming in the cosmetics.

The pharmaceutical division, under segmentation by end-use industry, would continue dominating the magnesium stearate market in the years to come. This would be because of the growing demand for the compound in the expanding pharmaceutical industry, as a suitable filler, binder, and release agent for drugs. Owing to the rising demand for drugs, the consumption of the compound is increasing. In addition, pharma companies are investing heavily in the research and development for new products, thereby helping raise the usage of the salt.

The most prominent players in the global magnesium stearate market are Peter Greven GmbH & Co. KG, Baerlocher GmbH, James M. Brown Ltd., Struktol Company of America LLC, Merck KGaA, Sinwon Chemical Co. Ltd., Haihang Industry Co. Ltd., Thermo Fisher Scientific Inc., Tokyo Chemical Industry Co. Ltd., and Hefei TNJ Chemical Industry Co. Ltd.

Source: www.psmarketresearch.com

Share:

Surging Steel Production Fueling Global Demand for Graphite

The increasing production of steel, due to the mushrooming requirement for steel products in end-use industries such as automotive, residential (household use), construction, and oil & gas, is fueling the global demand for graphite. As per the World Steel Association, the worldwide crude steel production increased from 1,814 million tons in 2018 to 1,869 million tons in 2019. Graphite exhibits high corrosion resistance and excellent strength and durability at extreme temperatures.

This is why it is extensively used in steel production. Besides, the ballooning demand for lithium-ion (Li-ion) batteries, on account of the increasing electric vehicle deployment, is also propelling the sales of graphite across the world. Each lithium-ion battery needs 10–20 times more graphite than lithium, as the greater the quantity of graphite, the more will be the battery’s capacity to intercalate lithium. Moreover, graphite is majorly used as an anode in the Li-ion batteries.

As natural graphite is cheaper than synthetic graphite and lithium titanate, the mushrooming sales of Li-ion batteries are driving the worldwide demand for graphite. This is, in turn, causing the expansion of the global graphite market. As a result, the revenue of the market is predicted to rise from $19,092.9 million in 2019 to $36,889.1 million by 2030. Furthermore, the market is predicted to advance at a CAGR of 7.4% from 2020 to 2030.

Hence, it is safe to say that the demand for graphite will shoot up in the forthcoming years, primarily because of its increasing usage in the steel production process and Li-ion batteries and the mushrooming production of steel and the ballooning sales of Li-ion batteries, on account of the growing deployment of electric vehicles, across the world.

Key Findings of Global Graphite Market Report

• Growing steel production driving graphite usage

• Synthetic form of material more popular than natural form

• Graphite use in pebble-bed nuclear reactors is key industry trend

• Automotive sector displaying highest potential for graphite adoption

• Seeing fragmented market nature, players engaging in acquisitions

• Highest graphite consumption being witnessed in APAC

Share:

Surging Oil and Gas Production Propelling Worldwide Demand for Benzalkonium Chloride

The rapid expansion of the pharmaceutical industry is massively augmenting the demand for benzalkonium chloride across the world. This is because this compound is heavily used in the pharmaceutical industry, because of its ability to be used as a disinfectant, antiseptic, solubilizing agent, wetting agent, and antimicrobial preservative. Moreover, with the rising income of people and the surge in healthcare expenditure in several countries, the affordability of various healthcare services is growing rapidly.

As per the U.S. Energy Information Administration (EIA), 101.2 million barrels of petroleum and various other associated liquids were used per day in 2019, which was higher than the 100.4 million barrels of petroleum used per day in 2018. The mushrooming requirement for these products is augmenting oil and gas exploration and production activities, which is, in turn, propelling the sales of benzalkonium chloride across the globe. This is consequently causing the boom of the global benzalkonium chloride market.

As a result, the revenue generated by the market is predicted to surge from $525.0 million in 2019 to $1,301.1 million by 2030. Furthermore, the market is predicted to grow at a CAGR of 9.6% from 2020 to 2030. Depending on application, the benzalkonium chloride market is divided into hand sanitizers; eye, ear, and nasal drops; shampoos, spermicidal creams, disinfectants, water treatment chemicals, timber protection chemicals, aquaculture chemicals, and coatings. 

Amongst these, the disinfectants category is predicted to register the highest growth in the market in the future years. This will be because of the compound’s ability to easily remove unwanted algae, viruses, fungi, and bacteria. When type is taken into consideration, the benzalkonium chloride market is classified into benzalkonium chloride 80% and benzalkonium chloride 50%. Between these, the benzalkonium chloride 50% category is predicted to hold larger share (by volume) in the market in the upcoming years.

This is because the compound is highly suitable for use in various personal care and pharmaceutical applications, on account of its less-toxic nature than the other variant. Globally, the benzalkonium chloride market will exhibit the fastest growth in the Asia-Pacific (APAC) region in the forthcoming years, as per the estimates of the market research firm, P&S Intelligence. This will be due to the growing requirement for various disinfectant products in the region, because of the outbreak of the COVID-19 pandemic.

Hence, it can be said with full surety that the demand for benzalkonium chloride will rise sharply across the world in the coming years, mainly because of the growing usage of the compound in the pharmaceutical, personal care, and oil & gas industries.

Share:

Increasing Oil and Gas E&P Activities Fueling Global Demand for Well Cementing

With the surge in exploration and production (E&P) activities in both unconventional and conventional oil and gas reserves, the demand for well cementing is growing rapidly all over the world. Moreover, because of the recovery of crude oil prices, the oil and gas industry is booming, which is, in turn, propelling the requirement for well cementing. The soaring E&P investments in countries such as China, Russia, Brazil, and the U.S. are fueling the expansion of the well cementing industry. 

Due to the above-mentioned factors, the demand for well cementing is rising sharply across the world. This is fueling the progress of the global well cementing market. The valuation of the market is predicted to grow from $7,577.6 million in 2018 to $10,065.4 million by 2024. Furthermore, the market is predicted to progress at a CAGR of 4.7% between 2019 and 2024. Well cementing is used in shale gas, oil, and gas wells. 

Out of these, the requirement for well cementing is predicted to grow rapidly in shale gas wells in the forthcoming years. This will be because of the rising demand for shale gas and the soaring investments being made in E&P activities in shale gas reserves. When application is taken into consideration, the well cementing market is divided into offshore and onshore. Between these, the offshore category is predicted to demonstrate faster growth in the market in the coming years.

This will be due to the surging investments made in offshore exploration activities and the discovery of several major offshore reserves in several regions. Globally, the well cementing market recorded the highest growth in North America in the past, as per the observations of P&S Intelligence, a market research company based in India. This was because of the huge investments made in the oil and gas sector, especially in well drilling for extracting shale gas in Canada and the U.S. 

Hence, it can be said with full confidence that the demand for well cementing will rise across the world in the coming years, mainly because of the soaring exploration and production activities in both offshore and onshore oil and gas reserves around the world.

Source: www.psmarketresearch.com

Share:

How is Growing Demand for Paints and Adhesives Driving Methylene Chloride Market?

The demand for methylene chloride is exploding all over the world, on account of its usage as a key solvent in various paint and adhesive formulations. Due to its low flammability, quick drying characteristics, and strong dissolving strength, methylene chloride is heavily used as a solvent in adhesive and paint formulations. With the mushrooming requirement for paints and adhesives, on account of the launch of various construction projects, the demand for methylene chloride is rising sharply across the world.  

Besides the aforementioned factor, the surging sales of automobiles, especially in the developing countries, are also pushing up the sales of paints and adhesives across the globe. This is, in turn, propelling the demand for methylene chloride all over the world, which is consequently driving the advancement of the global methylene chloride market, as per the observations of P&S Intelligence, a market research company based in India. Methylene chloride is basically an organic compound and has the formula- CH2Cl2.

The other major application areas of methylene chloride are photographic films, inks, and electronics. Out of these, the usage of the compound was found to be the highest in chemical and foam manufacturing processes during the past few years. This was because of the huge requirement for the compound in foam manufacturing and chemical processing processes, on account of its excellent blowing performance and large-scale usage in specialty chemical formulations.

Geographically, the Asia-Pacific region emerged as the largest methylene chloride market in the past, which is primarily ascribed to the surging production of the chemical in the region, rapidly growing population, and increasing infrastructural activities. In APAC, China and India are among the major consumer of the chemical. Furthermore, companies in the domain from across the globe are shifting their production bases to the APAC region, owing to the strict environmental regulations and rules laid down by the governments of various countries, primarily those in the European region, banning the utilization of methylene chloride in paint stripper applications. 

In conclusion, the demand for methylene chloride is being driven by the surging utilization of paints and adhesives in the construction industry. 

Share:

Increasing Application of Barium Nitrate in Military Sector

Barium nitrate is used in a considerable amount in the production of ceramic powder that is an important ingredient of electronic components, such as superconductors, capacitors, and semiconductors. The ceramic powder coating is used for device packaging, specialized mechanical components, and semiconductor devices. Besides, its application is increasing in the glass industry, as this compound helps in improving opacity and homogeneity of glasses. Moreover, it is used as an oxidizing agent during the production of glass, as it prevents crystallization of glass, thus, leading to better productivity and output.

According to P&S Intelligence, the market is expected to progress at a CAGR of 5.5% during forecast period. Countries across the world are focusing on the expansion of the military sector, on account of rising investment, thus, boosting the demand for barium nitrate products. Furthermore, the application of these products will spur in North America, Asia-Pacific (APAC), and the Middle East, due to heavy investment by barium nitrate manufacturers.

Moreover, stable and continuous demand for barium nitrate products from the pyrotechnics/fireworks sector is expected to boost the adoption of this chemical in coming years. Barium nitrate acts as an intermediate chemical in the pyrotechnic industry and as an oxidizing agent to manufacture green fireworks. It is also used as a pyrotechnic colorant compound, which gives a specific color to the burning flame. Besides, the chemical is utilized in tracer bullet that allows shooter to detect the trajectory of a bullet with the naked eye. 

Thus, the broadening application base of barium nitrate is fueling the demand for this compound. This has led to the exponential growth in the production capacity of established market players, such as Angene International Ltd., Hebei Xinji Chemical Group Co Ltd., Jiaocheng Sanxi Chemical Co. Ltd., SNDB, Tennants Distribution Ltd., Basstech International Llc, Sakai Chemical Industry Co. Ltd., Solvay, and Xilan Chemicals Co. Ltd. Due to the strong presence of these companies, new players will face a lot of competition in terms of cost competitiveness, product quality, and supply reliability.

Therefore, the expansion of the military, electronics, and pyrotechnics industries will propel the demand for barium nitrate products in future.

Share:

How is Increasing Demand for Packaging Contributing toward Surge of Global Injection Molded Plastics Industry?

The mushrooming requirement for injection molded plastics in the automotive industry is one of the major factors fueling their sales across the world. These plastics are heavily used for manufacturing various automobile parts and components in order to reduce the overall weight of the automobile. Moreover, the rising requirement for lower vehicle weight because of the ballooning demand for higher fuel efficiency is propelling the usage of injection molded plastics in the automotive industry.

The implementation of strict regulations regarding the usage of medical grade polymers in the healthcare industry is propelling the demand for injection molded plastics across the world. This is, in turn, creating excellent growth opportunities for the injection molded plastics producing companies around the world. Due to these factors, the global injection molded plastics market is exhibiting huge expansion. As a result, the market value is predicted to grow from $283.5 billion in 2016 to $496.2 billion by 2025.

Geographically, the injection molded plastics industry will demonstrate the fastest growth in the Asia-Pacific (APAC) region in the upcoming years, as per the forecast of P&S Intelligence, a market research company based in India. This is credited to the mushrooming demand for packaging in the pharmaceutical, cosmetics and toiletries, and food and beverages industries and the ballooning consumption of soft drinks in the regional countries, on account of the rising average temperatures in these countries. 

Hence, it can be said with surety that the demand for injection molded plastics will shoot up all over the world in the forthcoming years, primarily because of their growing usage in the packaging and automotive industries.

Share:

What is the State of Adoption of Medical Robotic Systems in Healthcare Infrastructure?

The medical robotic systems market size is predicted to generate a revenue of $56.5 billion by 2030, increasing from $7.6 billion in 2019, advancing at a 20.2% CAGR during the forecast period (2020–2030). Based on type, the market is divided into radiosurgery, rehabilitation, automated dispenser, and surgical, out of which, the surgical division held the major share of the market during the historical period (2014–2019). This is due to the rising demand for minimally invasive robotic surgeries. 

The geriatric population has been increasing rapidly all across the globe since the past few years. A report by the United Nations stated that the number of people aged 60 years or above was 962 million in 2017, which is expected to rise to 2.1 billion in 2050 and to 3.1 billion in 2100. This increasing number of aged people is bound to add to the global healthcare burden and financial burden, owing to which, there is a need for innovative means for dealing with this situation.

To learn more about this report: https://bit.ly/2JmPBzn

In addition to this, the demand for robotic procedures has actually been rising all over the world. As per a study in the Journal of the American Medical Association in 2020, about 15.1% of all the general surgeries in 2018 were robot-assisted procedures. The utilization of robotic surgeries has risen by 8.8% in the first four years, after the adoption of the technology in hospitals.

In addition to this, the increasing demand for minimally invasive surgeries and rising funding by government authorities for medical robots are also leading to the increasing demand for medical robotic systems in the region. Moreover, the companies operating in the regional domain are actively involved in strategic developments and are focusing on raising funds for establishing their stronghold on the market. For example, Corindus Vascular robotics Inc. raised $15 million in February 2019 in a stock offering. 

In conclusion, the market has been registering growth due to the rapid technological advancements, rising acceptance of medical robotic systems, and surging aged population.

Read more: https://www.psmarketresearch.com/market-analysis/medical-robotic-systems-market

Share:

How are Rising Food Safety Concerns Driving Mass Spectrometry Market?

 Food quality and safety is a vital public health issue, and it has become a major concern for people these days due to the presence of chemicals, toxins, and pathogens in food. As per the University of Rhode Island Department of Food Safety Education, about 33 million people fall ill because of foodborne illnesses every year in North America. Food contamination can originate from various sources, for example food safety is affected by the quality of water that is utilized in the processing and production of food. For maintaining the quality and safety of food, the presence of required microorganisms and the ones which may lead to spoilage in food is mandatory. Hence, food companies and government authorities use various analytical techniques for monitoring contamination to detect and mitigate risks. Due to this, the demand for microbial identification devices, specifically those based on mass spectroscopy, is increasing, as this technique provides a versatile approach in testing food samples along with both qualitative and quantitative data.

Mass spectrometry technique is utilized to quantify and identify molecules in complex and simple mixtures. The identification and ascertainment are done by separating the ions based on their mass to charge ratio which is measured by making use of a mass spectrum. 

As per a study conducted by the P&S Intelligence, the global mass spectrometry market size reached a value of $4,948.3 million in 2015 and is predicted to register a CAGR of 8.1% in the coming years. Various applications of mass spectrometry include proteomics, clinical testing, environmental research, and drug discovery and development. Among all these, mass spectrometry was utilized the most for drug discovery & development during 2012–2015, as it helps in determining the structure of metabolites and drugs. The fastest growth in demand is expected to be witnessed by the application of proteomics.



To learn more about this report: https://bit.ly/3lt1wbD

Several end users of mass spectrometry include hospitals, academic & research institutes, pharmaceuticals, and life sciences & biotechnology sector. During the period 2012–2015, the largest demand for mass spectrometry was created by the pharmaceutical firms and the situation is going to remain the same in the coming years as well. Over 80% of a medicinal product is made up of excipients, moreover, as these excipients are administered in patients, establishing their purity is of utmost importance. Therefore, to enhance the quality of pharmaceutical excipients, the International Pharmaceutical Excipients Council worked together with the Pharmaceutical Quality Group, the European Fine Chemicals Group, and the European Association of Chemical Distributors to develop a certification scheme for excipient suppliers. The legislation formulated by these organizations enforces the use of mass spectrometry for screening impurities in pharmaceutical excipients.

Share:

What are Key Factors Powering Surge in Global Ambulatory EHR Industry?

The ambulatory EHR market is registering growth due to the rising usage of EHR solutions, adoption of healthcare intranet technologies (HCIT) and increasing government initiatives, and need for reducing the overall healthcare cost. The electronically stored medical records of patients, which include information about medical care and surgeries that do not require the patient to be admitted in a hospital or non-hospital settings, are called ambulatory EHR.

To learn more about this report: https://bit.ly/3mvbs5D

In terms of application, the ambulatory EHR market is divided into patient management, referral management, decision support, e-prescribing, practice management, population health management, and health analytics. Among these, the practice management application occupied the largest share of the market during the historical period (2013–2016) and is projected to retain its position during the forecast period. This is due to the several advantages of EHR implementation, such as increased efficiency of day-to-day operations of healthcare practices. E-prescribing is predicted to grow at the fastest pace during the forecast period.

Another factor driving the ambulatory EHR market is the surging need for reducing overall healthcare cost. The shift from traditional data record systems to ambulatory EHR records decreases the cost associated with storing the data. While before the data stored on paper required a lot of care while handling it, now with the introduction of ambulatory EHR, the data can be electronically stored with ease. As per the data published by the University of New Mexico Hospital, the hospital saved over $200,000 annually due to reduced overtime and healthcare cost.

Hence, the market is growing due to the rising need for decreasing overall healthcare cost and increasing adoption of HCIT.

Read more: https://www.psmarketresearch.com/market-analysis/ehr-market

Share:

What are the Key Factors Powering Revenue Growth in Anatomic Pathology Industry?

One of the biggest factors resulting in the increasing demand for anatomic pathology services across the world is the escalating prevalence of chronic diseases, such as hypertension, cancer, heart diseases, autoimmune diseases, liver cirrhosis, and kidney diseases, especially in low and middle-income countries (LMICs). According to a report of the World Health Organization (WHO), 9.6 million people died from cancer across the world in 2018. Furthermore, the report also states that almost 70% of the deaths from cancer occur in LMICs, which, in turn, boosts the demand for anatomic pathology screening in these countries.

The other key factor responsible for the growth of the anatomic pathology market is the soaring geriatric population across the globe. As per the World Population Ageing published by the United Nations (UN), the global geriatric population is predicted to increase from 703 million in 2019 to 1.5 billion by 2050. Additionally, the WHO reports that the prevalence of chronic diseases, such as depression, diabetes, organ failure, dementia, and pulmonary diseases, increases with age, which further pushes the need for efficient diagnosis, thereby propelling the volume of pathological tests.

To learn more about this report: https://bit.ly/2JBwD7S

Geographically, the Asia-Pacific region is expected to observe the fastest growth in the demand for anatomic pathology testing during the forecast period. The main factors contributing to the surge in this region are the rising acceptance of personalized medicine, mushrooming patient pool suffering from chronic diseases, increasing investments by the governments of various APAC countries, as well as numerous non-government organizations, on diagnostic research, and increasing penetration of major companies in the region, which provide products for pathological screening.

Therefore, it can be concluded that owing to the ballooning need for quick and effective diagnosis of chronic diseases and rapid technological advancements in the healthcare industry, the usage of anatomic pathology testing is set to observe huge growth in the coming years.

Read more: https://www.psmarketresearch.com/market-analysis/anatomic-pathology-market

Share:

How is Surging Incidence of Hospital-Acquired Infections Driving Infection Surveillance Solutions Industry?

The prevalence of hospital-acquired infections (HAI) has been growing rapidly, with HAIs becoming among the key cause of mortality and morbidity in hospitalized patients, as per the World Health Organization (WHO). These infections are caused primarily by bacteria. Strains of bacteria found in medical settings are more resistant to antibiotics those found outside the hospital, owing to the fact that antibiotics are utilized frequently in hospitals. According to the WHO, about 7 and 10 of every 100 patients ion developed and developing countries, respectively, who are hospitalized, acquire at least one HAI at any given time.

To learn  more about this report: https://bit.ly/30zsWpo

Attributed to this, the demand for infection surveillance at hospitals and other medical facilities is growing rapidly. Traditionally, the surveillance of HAIs was done by reviewing medical charts, ward rounds, and paper-based reports of microbiologic results. The analysis then was done by assembling hand-written data or entering the information into a computer database, manually. However, these methods are labor intensive, time-consuming, and quite inefficient for coping with the rising complexity of antibiotic resistance. Because of this, these methods are become obsolete and witnessing a shift to computer-based surveillance. Due to these factors, the global infection surveillance solutions market is predicted to advance at a considerable pace in the coming years.

In addition to this, a large number of key companies that offer web-based and on-premises solutions to track and check the spread of HAIs are present in the region. This being said, the demand for these solutions and associated services is predicted to increase substantially in the Asia-Pacific region, thereby making it the fastest growing infection surveillance solutions market in the years to come. This is attributed to the growing awareness and accessibility to advanced healthcare facilities, rising healthcare expenditure, surging incidence of HAIs, and expanding health insurance sector in the region.

Hence, the requirement for infection surveillance solutions is growing due to the rising prevalence of HAIs across the globe.


Share:

Hospital Infection Therapeutics Market Overview, Key Players, Growth and Future Scope

 Hospitals or other medical facilities are particularly associated with the treatment of diseases and the idea of getting infected with a pathogen while being in the hospitals may be quite foreign to a lot of people. However, hospital infections or hospital-acquired infections affect a lot of people; for example, according to the World Health Organization, of every 100 patients that are hospitalized, at any given time, about 10 in developing and 7 in developed counties will acquire at least one hospital infection. In addition to this, newborns especially are at a higher risk of suffering from healthcare associated disease in emerging economies.

To learn more about this report: https://bit.ly/3mfxHN8

Some of the hospital infections are catheter-associated urinary tract infections, central line-associated blood stream infections, hospital-acquired pneumonia, surgical site infections, Clostridium difficile infections, and ventilator-associated pneumonia. Much like any other infection, the risk of hospital infections depends on the patient’s immune status. Other than this, prevalence of several pathogens in the local community and infection control practices are also major factors on which hospital infection depend. Some of the major risk factors for these infections include longer hospital stays, older age, multiple underlying chronic illnesses, recent invasive procedures, immunosuppression, frequent encounters with healthcare facilities, and mechanical ventilatory support.

Geographically, North America has emerged as the largest hospital infection therapeutics market in the past few years, which is attributed to the enhanced healthcare infrastructure, increased awareness regarding healthcare, high ratio of hospitals in comparison to the population, surging aging population, and rising count of multi drug resistant microbial pathogens in the region. Apart from this, the demand for hospital infection therapeutics is also expected to increase significantly in the Asia-Pacific region because of the rising incidence of hospital infections and high requirement for therapeutic drugs in countries including China and India.

In conclusion, the demand for hospital infection therapeutics is growing due to the rising incidence of hospital infections.

Read more: https://www.psmarketresearch.com/market-analysis/hospital-infection-therapeutics-market

Share:

Digital Pathology of Great Importance for Geriatric Population

The prevalence of chronic diseases, including cancer, around the world has been increasing rapidly. According to the World Health Organization, cancer is among the leading causes of death, second-leading to be precise, globally, and led to about 8.8 million deaths in 2015. In addition to this, approximately 70% increase is expected to be witnessed in the number of new of cancer cases over the next two years. Like cancer, there are a number of chronic diseases which still cannot be cured and can only be managed with proper medication. 

In such cases, early detection of the disease is the key to get effective treatment for the management of the disease. Because of this, the demand for advanced technologies that can provide faster and more accurate and efficient diagnosis is rising. As per a report by P&S Intelligence, the global digital pathology market size is projected to advance at a significant pace in the years to come. The process of digitizing glass slides by making use of a whole slide image scanner for analyzing the digital images by utilizing an image viewer, such as a mobile device or computer monitor, is referred to as digital pathology.

To learn more about this report: https://bit.ly/3lhvGid

The geriatric population especially is widely utilizing teleconsultation services, as they make the management of chronic diseases easy and reduce the number of hospital visits. Other than this, the demand for this technology is also predicted to rise substantially for disease diagnosis in the near future because of the increasing incidence of bacterial and viral diseases. Geographically, North America is predicted to emerge as the largest digital pathology market in the years to come. This is owing to the rising healthcare expenditure and supportive government initiatives about the development of technologically innovative systems in the region. 

In conclusion, the demand for digital pathology technology is growing because of the surging prevalence of chronic diseases and increasing geriatric population.

Read more: https://www.psmarketresearch.com/market-analysis/digital-pathology-market

Share:

What are Latest Technologies in Embolotherapy Market?

More than 840,000 new liver cancer cases were diagnosed around the world in 2018, according to the World Cancer Research Fund (WCRF). Similarly, other severe diseases, such as kidney cancer, aneurysms, and varicose veins, are also increasing in prevalence due to genetic predisposition, environmental factors, sedentary lifestyle, obesity, and alcohol abuse. The treatment or management of many such issues requires deliberately blocking the blood vessels to reduce the risk of bleeding or hemorrhage or to starve the tumor of blood, by inserting a balloon.

Therefore, with the increasing prevalence of the above-mentioned disorders, the global embolotherapy market size is predicted to grow at an 8.0% CAGR during 2019–2024 (forecast period), to reach $4.8 billion in 2024 from $3 billion in 2018. In normal but life-threatening situations, a blood clot or mass breaks off from a part of the body and travels through the artery, thereby stopping the blood flow. But, because the same is now being done for managing a disease, the process is known as embolotherapy, meaning treatment by creating an embolus.

To learn more about this report: https://bit.ly/36T4px2

There are three primary approaches to the procedure: transarterial radioembolization (TARE)/selective internal radiation therapy (SIRT), transcatheter arterial embolization (TAE), and transarterial chemoembolization (TACE). Among these, TAE is the preferred approach, because it has a better toxicity profile than TACE and TARE/SIRT, which means less complication for the patients. During the procedure, the inner thigh is incised, and a catheter, which is a thin, flexible tube, is snaked through the femoral artery to a smaller artery near the site of the tumor or unhealthy tissue. Once the catheter is in place, tiny gelatin sponges are administered to stop the tumor’s blood supply.

Presently, North America witnesses the highest number of such procedures, as the incidence of various diseases which require these is rising in the continent. Moreover, the continent has the most advanced healthcare infrastructure in the world, and several improved embolic agents are being launched by biopharmaceutical companies. In the coming years, the most rapid embolotherapy market growth would be witnessed in Asia-Pacific (APAC), on account of the expansion in the pool of patients with advanced-stage cancers and rising expenditure on healthcare, which is leading to improvements in the medical infrastructure in the region.

Thus, with further advancements in the management methods for cancer and other advanced-stage diseases, which would lead to the availability of enhanced embolic agents, the preference for embolotherapy would keep surging.

Read more: https://www.psmarketresearch.com/market-analysis/embolotherapy-market

Share:

Growing Prevalence of Autoimmune Diseases to Fuel $10,012.9 Million Revenue in Autoimmune Disease Diagnostics Market in 2030

The rising incidence of autoimmune diseases, growing geriatric population, advent of novel biomarkers, increasing initiatives being taken by various government and private organizations for raising public awareness about autoimmune diseases, and the soaring strategic development projects and activities being launched by the market players are the key factors fueling the expansion of the global autoimmune disease diagnostics market. Furthermore, the market is predicted to attain a valuation of $10,012.9 million in 2030, exhibiting a CAGR of 8.5% from 2020 to 2030.

To learn more about this report: https://bit.ly/2UTn0DC

Based on product, the autoimmune disease diagnostics market is categorized into instruments and consumables and assay kits. Of these, the consumables and assay kits category is predicted to dominate the market in the future years, on account of the growing incidence of autoimmune diseases and the rising requirement for tests, such as enzyme-linked immunosorbent assay (ELISA), rheumatoid factor (RF) & anti-cyclic citrullinated peptide (CCP) antibody, and antinuclear antibody (ANA) immunofluorescence assay (IFA).

Globally, the North American autoimmune disease diagnostics market is predicted to exhibit lucrative growth in the upcoming years, owing to the rapid improvements in healthcare facilities and infrastructure, growing prevalence of autoimmune diseases, rising research activities, soaring geriatric population, and the existence of several leading market players in the region.

Browse full report at: https://www.psmarketresearch.com/market-analysis/autoimmune-disease-diagnostics-market-report

Some of the major market players are A. Menarini Diagnostics S.r.l., Bio-Rad Laboratories Inc., Adaltis S.r.l., Sigma Diagnostics Inc., ORGENTEC Diagnostika GmbH, PerkinElmer Inc., Inova Diagnostics, ELITech Group, Grifols S.A., HYCOR Biomedical, Exagen Inc., Cambridge Life Sciences Limited, Trinity Biotech plc, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Seramun Diagnostica GmbH, Siemens AG, bioMérieux S.A., Thermo Fisher Scientific Inc., Danaher Corporation, and Abbott Laboratories.

Share:

How is Rising Healthcare Expenditure Driving Exoskeleton Industry?

The global exoskeleton market size is projected to reach a value of $6,957.9 million by 2030. The primary factor leading to the growth of the market are the rising healthcare expenditure, increasing number of stroke cases and spinal cord injuries (SCIs), surge in the penetration of products in military and industrial operations, growing geriatric population, and rising job opportunities for disabled people.

To learn more about this report: https://bit.ly/331VB75


When component is taken into consideration, the exoskeleton market is classified into software and hardware, between which, the hardware classification held the larger share of the market in 2019. Exoskeletons consist of several hardware components and passive exoskeletons are particularly constructed using hardware parts, thereby leading to the growth of the classification. The hardware classification is further divided into control systems, power sources, actuators, and sensors. On the basis of mobility, the market is divided into mobile and stationary.

Geographically, the exoskeleton market was dominated by North America in 2019, and is region is predicted to contribute the largest revenue share to the market during the forecast period as well. Exoskeletons are extensively being used by military personnel and the healthcare sector. In addition to this, the regional market is growing because of the rising workforce of disabled people and increased availability of these products. The Asia-Pacific region is expected to register the fastest growth during the forecast period.

In conclusion, the increasing number of SCIs and stoke cases and rising healthcare expenditure are driving the growth of the market.

Read more: https://www.psmarketresearch.com/market-analysis/exoskeleton-market-forecast

Share:

What are Factors Contributing to Boom of Hospital Capacity Management Solutions Market in U.S.?

The rising demand for better healthcare facilities and rapid technological advancements in the healthcare sector are the major factors fuelling the demand for hospital capacity management solutions across the world. In addition to this, the mushrooming investments being made by several healthcare information technology (HIT) companies, soaring number of hospitals, and burgeoning need for integrated healthcare solutions are further pushing the demand for these solutions throughout the world. Propelled by these factors, the global hospital capacity management solutions market is expected to exhibit huge growth in the coming years.

To learn more about this report: https://bit.ly/3pIUKlh

Globally, North America and Europe are observing the highest usage of hospital capacity management solutions. This is primarily attributed to the increasing incidence of chronic diseases, soaring geriatric population, higher healthcare expenditure, and improving healthcare infrastructure in these regions. Moreover, the swift technological advancements in such software, the rising awareness regarding the applications of these solutions, and raging COVID epidemic are significantly contributing to the growing demand for these solutions in these regions. In North America and Europe, the U.S. and Italy, respectively, are witnessing the widest adoption of such solutions.

Latin America is another region witnessing a rapid rise in the adoption of these solutions. The main factors responsible for the boom of the hospital capacity management solutions market in LATAM are the increasing healthcare expenditure in the region, a major chunk of which is being spent on integrating IT functionalities in the medical sector. In this region, Brazil, on account of the rising support from numerous government organizations and developing healthcare infrastructure, is observing the highest implementation rate of hospital capacity management solutions.

Browse full report at: https://www.psmarketresearch.com/market-analysis/hospital-capacity-management-solutions-market

This Study Covers

• Historical and the present size of the hospital capacity management solutions market

• Major factors driving the market and their impact during the short, medium, and long terms

• Market restraints and their impact during the short, medium, and long terms

• Recent trends and evolving opportunities for the market participants

• Historical and the present size of the market segments and understand their comparative future potential

• Potential of on-demand logistics services, so the market players make informed decisions on the sales of their offerings

Share:

Increasing Stem Cell Transplant Procedures Pushing Up Medical Gloves Sales in Asia-Pacific

With the recent outbreaks of various contagious diseases such as Middle East respiratory syndrome (MERS), Zika, severe acute respiratory syndrome (SARS), and Ebola, medical gloves are increasingly becoming extremely essential in healthcare operations. The outbreak of the COVID-19 (SARS CoV-2) pandemic has further pushed up the requirement for medical gloves, on account of their ability to prevent direct contact between persons, which is very essential for reducing the spread of the coronavirus.


Moreover, as the coronavirus is transmitted via direct contact and droplets, medical authorities and governments are increasingly mandating the use of medical gloves for people and healthcare workers. Researchers have found that protective medical equipment such as examination and surgical gloves reduce the spread of infection by a huge margin. Apart from contagious diseases, the increasing incidence of chronic diseases is also driving the sales of medical gloves across the world.

As per a study conducted by P&S Intelligence, the medical gloves market size is progressing at a 10.8% CAGR during the forecast period. The market has been registering growth due to the increasing risk of contagious diseases, rising volume of surgeries, surging geriatric population, growing healthcare spending, and increasing burden of chronic diseases across the globe.

Browse full report at: https://www.psmarketresearch.com/market-analysis/medical-gloves-market-report

As per the Organisation for Economic Co-operation and Development (OECD), in Japan, 5,032 stem cell transplant procedures were performed in 2010. Furthermore, the country witnessed a sharp rise in stem cell transplants in the next few years and recorded 5,609 procedures in 2015. Similarly, the number of transluminal coronary angioplasties increased in Australia from 37,600 to 45,517 from 2010 to 2017. This massive rise in the number of surgeries pushed up the sales of medical gloves in the country.

Therefore, it can be said without any doubt that the sales of medical gloves are predicted to rise enormously all over the world in the coming years, primarily because of the growing incidence of contagious and chronic diseases, the recent outbreak of the COVID-19 pandemic, and the rising awareness about hygiene among the people and healthcare practitioners.

Share:

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?

Every year, over 9.5 million people die as result of cancer, as per the World Health Organization (WHO), thereby becoming one of the major reasons for human mortality around the world. The disease, which is most prominently characterized by the presence of tumors, forms when a mutation (undesirable change) in a gene or protein causes a particular type of cell to divide faster than the rate of the normal cell death, thereby resulting in the growth of a visible mass. For effective treatment, merely detecting the tumor within the body is not enough; its nature and the exact mutation which caused it also need to be studied.

Therefore, owing to the increasing number of people suffering from this disease and the high focus on deeply studying its various aspects, in order to device an effective therapy, the cancer/tumor profiling market is growing around the world. Several technologies, including quantitative polymerase chain reaction (QPCR), next-generation sequencing (NGS), in-situ hybridization (ISH), immunohistochemistry (IHC), and microarray, are used to study the tumors. Of these, NGS has been the most widely preferred till now, on account of its ability to quickly detect the sequencing of the deoxyribonucleic acid (DNA) in the genome.

To learn more about this report: https://bit.ly/38zw6gZ

Another important application area of cancer/tumor profiling is biomarker discovery. A biomarker is any substance against which the reaction of a disease is studied to determine its nature and severity. The most common biomarkers are antigens, which help detect the presence of infections. Seeing the rising complexities in cancer diagnosis, many biotechnology firms are coming up with innovative biomarkers for effective diagnosis. For instance, several biomarkers have been developed by Caris Life Sciences, by using ISH, IHC, and NGS, for the detection of translocation, protein expression, and fusion levels, analysis of gene amplification and deletion, and broad detection and rapid examination of DNA mutations.

Presently, the most productive cancer/tumor profiling market is North America, on account of the heavy investments in cancer research and therapy areas. Moreover, numerous technological advancements are taking place in the healthcare industry of the region, which are resulting in the introduction of more-advanced profiling techniques. In the region, the prevalence of common as well as rare cancers is rising, which is leading to increasing complexities in the diagnosis procedure. Asia-Pacific (APAC) would witness the fastest increase in the adoption of cancer/tumor profiling approach in the immediate future, due to the increasing government funding for cancer research and treatment, as well as rising cases of the disease.

Therefore, on account of the improvements in diagnosis methods, the demand for cancer/tumor profiling products and services will keep surging.

Read more: https://www.psmarketresearch.com/market-analysis/cancer-profiling-market


Share:

Follow Me

Powered by APSense.com

Follow Me

Follow on LinkedIn

Followers

Total Pageviews

Popular Posts

Recent Posts

Label Cloud